Home » Topics » Disease categories and therapies » Urology

Urology
RSS

PT-141 effective in ED patients who fail to respond to Viagra

Jan. 24, 2003

European launch of Cialis under way

Jan. 24, 2003

IPD-1151T licensed to Yamanouchi for global development in cystitis and prostatitis

Jan. 23, 2003

Potent, selective PDE5 inhibitors prepared and tested at Lilly Icos

Jan. 22, 2003

Long-term effects of tranilast in oligoasthenozoospermia

Jan. 20, 2003

Possible explanation for sildenafil-associated thrombotic conditions

Jan. 20, 2003

ARYx reports new anticholinergics with utility in urinary incontinence and COPD

Jan. 20, 2003

GSK launches Avodart for BPH in U.S.

Jan. 16, 2003

Collegium enters antibody licensing agreement with Tufts for HUS

Jan. 15, 2003

Possible treatment for IgA nephropathy being developed by CuraGen and Abgenix

Jan. 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...